Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
review article or handbook
Title:
Unnamed
Year:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
GLP compliance:
not specified
Type of study:
guinea pig maximisation test

Test material

Constituent 1
Reference substance name:
Isopulegol
EC Number:
201-940-6
EC Name:
Isopulegol
Cas Number:
89-79-2
IUPAC Name:
2-isopropenyl-5-methylcyclohexanol
Constituent 2
Chemical structure
Reference substance name:
5-methyl-2-(1-methylvinyl)cyclohexan-1-ol
EC Number:
232-102-8
EC Name:
5-methyl-2-(1-methylvinyl)cyclohexan-1-ol
Cas Number:
7786-67-6
Molecular formula:
C10H18O
IUPAC Name:
5-methyl-2-(prop-1-en-2-yl)cyclohexan-1-ol
Details on test material:
Name of test material: Isopulegol

In vivo test system

Test animals

Species:
guinea pig
Strain:
Hartley
Sex:
female

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
polyethylene glycol
Concentration / amount:
The 1st injection consisted of 10% w/v in Complete Adjuvant (CA), 2nd injection consisted of 10% w/v in a mixture of Freund’s and 3rd
injection consisted of complete adjuvant plus physiological saline(1:1).
A topical induction consisted of isopulegol at 10% concentration w/v in CA.
Then the topical challenge application was made to the clipped left anterior flank with 0.1 ml aliquot of isopulegol at 5%, 10%, 20% or 40% w/v
in a mixture of propyleneglycol plus acetone (1:1).
Challengeopen allclose all
Route:
epicutaneous, open
Vehicle:
polyethylene glycol
Concentration / amount:
The 1st injection consisted of 10% w/v in Complete Adjuvant (CA), 2nd injection consisted of 10% w/v in a mixture of Freund’s and 3rd
injection consisted of complete adjuvant plus physiological saline(1:1).
A topical induction consisted of isopulegol at 10% concentration w/v in CA.
Then the topical challenge application was made to the clipped left anterior flank with 0.1 ml aliquot of isopulegol at 5%, 10%, 20% or 40% w/v
in a mixture of propyleneglycol plus acetone (1:1).
No. of animals per dose:
Five animals were assigned to the test group and five animals to the control

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Reading:
rechallenge
Hours after challenge:
24
Group:
test chemical
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 24.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 5.0.
Reading:
rechallenge
Hours after challenge:
48
Group:
test chemical
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
other: Reading: rechallenge. . Hours after challenge: 48.0. Group: test group. No with. + reactions: 0.0. Total no. in groups: 5.0.

Any other information on results incl. tables

Any animals experimented skin sensitizing reactions under these conditions of study.

Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
No sensitization observed in guinea pig maximization test (GPMT)